investorscraft@gmail.com

Intrinsic ValueOxford Instruments plc (OXIG.L)

Previous Close£2,515.00
Intrinsic Value
Upside potential
Previous Close
£2,515.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Oxford Instruments plc operates as a leading provider of high-technology tools and systems for research and industrial applications, serving sectors such as semiconductors, renewable energy, and healthcare. The company’s diversified portfolio includes atomic force microscopy, etch and deposition processing equipment, low-temperature systems, and nuclear magnetic resonance instruments, catering to specialized markets with high barriers to entry. Its solutions are critical for advanced research in quantum technology, materials science, and life sciences, positioning it as a key enabler of innovation. Oxford Instruments maintains a strong global presence, with operations spanning the UK, China, Japan, the US, and Europe. The company’s focus on niche, high-margin markets allows it to command premium pricing and foster long-term customer relationships. Its expertise in precision instrumentation and analytical systems differentiates it from broader industrial competitors, reinforcing its leadership in scientific and industrial research tools. By continuously investing in R&D and strategic acquisitions, Oxford Instruments strengthens its technological edge and expands its addressable market.

Revenue Profitability And Efficiency

Oxford Instruments reported revenue of £470.4 million for FY 2024, with net income of £50.7 million, reflecting a disciplined approach to cost management and operational efficiency. The company generated £42.4 million in operating cash flow, though capital expenditures of £27.0 million indicate ongoing investments in growth initiatives. Its ability to maintain profitability in a capital-intensive industry underscores its competitive positioning.

Earnings Power And Capital Efficiency

The company’s diluted EPS of 87p demonstrates its earnings resilience, supported by a diversified revenue base and high-margin product lines. Oxford Instruments’ capital efficiency is evident in its ability to generate positive cash flow while funding R&D and strategic expansions, ensuring sustainable returns for shareholders.

Balance Sheet And Financial Health

Oxford Instruments maintains a robust balance sheet, with £97.8 million in cash and equivalents against £47.4 million in total debt, reflecting a conservative leverage profile. This financial stability provides flexibility for strategic investments and mitigates risks associated with cyclical demand in its end markets.

Growth Trends And Dividend Policy

The company has demonstrated consistent growth, driven by demand for advanced research tools and industrial applications. Its dividend per share of 21p reflects a commitment to returning capital to shareholders while retaining sufficient funds for reinvestment. Oxford Instruments’ growth trajectory is supported by secular trends in semiconductor and renewable energy markets.

Valuation And Market Expectations

With a market capitalization of approximately £1.05 billion and a beta of 0.98, Oxford Instruments is valued as a stable, growth-oriented player in the technology sector. The market appears to price in its leadership in niche markets and its ability to sustain margins despite macroeconomic uncertainties.

Strategic Advantages And Outlook

Oxford Instruments’ strategic advantages lie in its technological expertise, global footprint, and focus on high-growth sectors like quantum technology and advanced materials. The outlook remains positive, supported by increasing R&D spending across industries and the company’s ability to innovate. Long-term growth will likely hinge on its capacity to expand into emerging markets and maintain its technological leadership.

Sources

Company filings, London Stock Exchange disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount